First-in-human phase 1 trial of the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of WSD0922-Fu: Initial report from dose escalation cohort

Authors
Category Primary study
JournalJOURNAL OF CLINICAL ONCOLOGY
Year 2023
This article has no abstract
Epistemonikos ID: 4f8402510bba7153ab023713614094f08ee2ace1
First added on: Feb 19, 2025